3 listed pharmas showing danger signal in financial structure
Although most listed pharmaceutical companies were evaluated to have a sound financial structure, some pharmaceutical companies were criticized to show a danger signal on soundness of the financial structure.
Yakup Shinmoon(www.yakup.com) analyzed 61 KOSPI and KOSDAQ listed pharmaceutical compan...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.